Skip to content

AIM round-up: Bezant Resources, Roebuck Foods, MJ Hudson


Taking a slightly earlier cut today owing to a number of factors but at 2pm, London’s AIM Index had managed to consolidate some gains, sitting up around two points on the day at 1203.18.

  • Bezant Resources
  • Roebuck Foods
  • MJ Hudson
  • DX Group
  • Omega Diagnostics

Bezant Resources LON:BZT was leading the board by 2pm today although trade in the stock has been rather lumpy and it does sit on a 12.5% spread. A couple of positive updates earlier in the week didn’t seem to offer much traction so this could just be a case of that sentiment finally coming through on the price.

Roebuck Foods LON:RFG are once again on the radar with shares up 17% at the time of writing. The stock was truly demolished at the start of the week after a big cash return was made to shareholders and trade since has been rather thin. There’s little to justify the move given the quoted spread of 33%, but evidently some see future value down at this level.

A notable mention for MJ Hudson LON:MJH who we covered in the pre-market report earlier. Their upbeat full year results and promise of a dividend clearly lifted sentiment with investors evidently supportive of the fairly aggressive growth through acquisition model that has been laid out. Shares sat 7% higher by mid-afternoon.

DX Group [LON:DX] found itself slumped at the bottom of the table, down 37% in the wake of this morning’s news that it was unlikely to be able to file its accounts in line with the six month AIM deadline and as such expects the shares to be delisted early in the new year. However with strong growth plans, the question to be asked is if there’s value to be had down here.

A half year report from MedTech Omega Diagnostics LON:ODX saw the share price slip 28% by 2pm this afternoon. Despite a return to pre-pandemic levels of sales in some areas such as health & nutrition, a lack of visibility over COVID-related sales seems to have taken the edge off sentiment. Shares now sit at levels not seen since the early days of the global health crisis.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top